It contains the same active ingredient as the injection and works the same way, so the benefits, side effects, and FDA-approved uses are largely the same as the Wegovy pen the main difference is how its taken
This suggests that once GLP-1 receptor agonism is maximized, adding a norepinephrine-based appetite suppressant may not offer the additional benefit that the complementary mechanism theory predicts
Are There Risks Associated with Compounded GLP1 Injections
Kruczkowska W, Gaziewska J, Kciuk M, et al
Some practitioners recommend minimizing NSAIDs while on BPC-157 since NSAIDs can blunt the growth factor responses BPC-157 initiates
In addition, some side chains are covalently modified after synthesis in vivo (post-translational modificationssee below)